APA

Amidfar M., Khiabany M., Kohi A., Salardini E., Arbabi M., Roohi Azizi M., Zarrindast M., Mohammadinejad P., Zeinoddini A. & Akhondzadeh S. (20170517). Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study. : Journal of clinical pharmacy and therapeutics.

Chicago

Amidfar M, Khiabany M, Kohi A, Salardini E, Arbabi M, Roohi Azizi M, Zarrindast M-R, Mohammadinejad P, Zeinoddini A and Akhondzadeh S. 20170517. Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study. : Journal of clinical pharmacy and therapeutics.

Harvard

Amidfar M., Khiabany M., Kohi A., Salardini E., Arbabi M., Roohi Azizi M., Zarrindast M., Mohammadinejad P., Zeinoddini A. and Akhondzadeh S. (20170517). Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study. : Journal of clinical pharmacy and therapeutics.

MLA

Amidfar M, Khiabany M, Kohi A, Salardini E, Arbabi M, Roohi Azizi M, Zarrindast M-R, Mohammadinejad P, Zeinoddini A and Akhondzadeh S. Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study. : Journal of clinical pharmacy and therapeutics. 20170517.